Beta Med Pharmaceuticals, Inc.
Country not established
- Devices
- 1
What Beta Med Pharmaceuticals, Inc. makes
Beta Med Pharmaceuticals, Inc. manufactures the OCCULT-ALERT, a diagnostic device designed to detect occult blood in stool samples, commonly used in colorectal cancer screening and gastrointestinal diagnostics.
The company’s portfolio is regulated under Class II devices in the United States, with the OCCULT-ALERT authorised via the FDA’s 510(k) clearance process. The manufacturer operates from the US.
Catalogue
Occult-Alert Ref K830919
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Beta Med Pharmaceuticals, Inc. have in the registry?
The registry currently lists 1 device for Beta Med Pharmaceuticals, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Beta Med Pharmaceuticals, Inc.'s devices?
Among its 1 most recently registered device, Beta Med Pharmaceuticals, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Beta Med Pharmaceuticals, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Beta Med Pharmaceuticals, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Beta Med Pharmaceuticals, Inc. in the registry?
The most recently registered devices listed for Beta Med Pharmaceuticals, Inc. include OCCULT-ALERT.